IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Glenmark Pharmaceuticals LT INR 1.0

Q4 2023 vs Q1 2024

Comparing institutional holders between quarters

Quarters

Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile
Stanley-Laman Group, Ltd.
DECREASED
Shares150,000 from 210,000
Change-60,000 (-29%)
Value$1.7M (-$433.1K)
Filed 2024-04-17
Status
Stanley-Laman Group, Ltd.
DECREASED150,000210,000-60,000-29%$2.2M$1.7M-$433.1K2024-04-17
Showing 1 of 1 institutions